Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a new version of the page in the history.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision entry, v3.6.5, was added to the study record history and the previous revision, v3.6.4, was removed. This update represents changes to the page’s versioning metadata rather than alterations to the study data.SummaryDifference0.1%

- Check40 days agoChange DetectedThe history page now reflects Revision: v3.6.4 instead of v3.6.3. This indicates a new software revision was applied to the Record History page.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry 'Revision: v3.6.3' is added to the history and the previous 'Revision: v3.6.2' is removed, indicating a software release update to the record history.SummaryDifference0.1%

- Check69 days agoChange DetectedThe revision label in the history table changes from v3.6.0 to v3.6.2, representing a minor update to the page metadata. No user-facing content or functionality is altered.SummaryDifference0.1%

- Check83 days agoChange DetectedRecruitment status updated to 'No longer looking for participants,' indicating that recruitment for this study has ended. The study history also shows a new revision label v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.